Recent work by Potez et al. demonstrated the feasibility of growing TILs across ccRCC, pRCC, and unclassified histologies (uRCC), with expanded T-cells from pRCC and uRCC demonstrating a greater proportion of CD4+ T-cells compared to ccRCC tumors [191]. This evidence concerns the gene CD4 and Unclassified Renal Cell Carcinoma.